Myomo (MYO) Other Long Term Assets: $0.59 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MYO Myomo Inc MYO
55 GF Score
Price $1.30
GF Value $3.24
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Myomo Other Long Term Assets?

Myomo MYO 55 Other Long Term Assets is $0.59 Mil as of Jun. 2026. GuruFocus rates MYO with a GF Score™ of 55/100 and a GF Value™ of $3.24 (Possible Value Trap). The stock has 5 warning signs investors should review.

Myomo's other long-term assets for the quarter that ended in Jun. 2026 was $0.59 Mil.

Myomo's quarterly other long-term assets declined from Dec. 2025 ($0.60 Mil) to Mar. 2026 ($0.60 Mil) but then stayed the same from Mar. 2026 ($0.60 Mil) to Jun. 2026 ($0.59 Mil).

Myomo's annual other long-term assets increased from Dec. 2023 ($0.09 Mil) to Dec. 2024 ($0.54 Mil) and increased from Dec. 2024 ($0.54 Mil) to Dec. 2025 ($0.60 Mil).

Myomo Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Myomo's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Myomo Other Long Term Assets Chart

Myomo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.11 0.09 0.54 0.60

Myomo Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.54 0.60 0.60 0.59
MYO
55GF Score
Myomo Inc MYO
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Myomo Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.59 Mil mean?
Myomo (MYO) has a Other Long Term Assets of $0.59 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Myomo and its competitors.
Is Myomo's Other Long Term Assets too high?
Myomo's current Other Long Term Assets is $0.59 Mil. Overall, Myomo has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Myomo's Other Long Term Assets compare to NNOX and SRTS?
Myomo's Other Long Term Assets of $0.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Devices & Instruments company?
A good Other Long Term Assets depends on the Medical Devices & Instruments industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Myomo and its competitors. Myomo's current Other Long Term Assets is $0.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Myomo stock overvalued right now?
Based on GuruFocus' analysis, Myomo (MYO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.24, compared to a current price of $1.30 — trading 59.9% below its estimated fair value. The current Other Long Term Assets is $0.59 Mil. Myomo's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Myomo (MYO), the current Other Long Term Assets is $0.59 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Myomo (MYO) Overvalued in 2026?

Based on GuruFocus' analysis, Myomo stock appears to be undervalued. The current stock price of $1.30 is trading 59.9% below its estimated GF Value™ of $3.24. GuruFocus considers Myomo to be Possible Value Trap.

Key valuation signals for MYO:

  • Other Long Term Assets: $0.59 Mil
  • GF Value™: $3.24 vs. price of $1.30 (59.9% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the MYO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Myomo Business Description

Other Exchanges 0M61:Germany
Address 45 Blue Sky Drive, Suite 101, Burlington, MA, USA, 01803
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
55GF Score

Get the complete analysis for MYO

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.30
Price
$3.24
GF Value